No genetic association between the SLC1A2 gene and Japanese patients with schizophrenia

Neuroscience Letters

Volumn 463, Issue 3, 2009, Pages 223-227

  Nagai, Yasuhito ^a   Ohnuma, Tohru ^a   Karibe, Jun ^a   Shibata, Nobuto ^a   Maeshima, Hitoshi ^a   Baba, Hajime ^a   Hatano, Tokiko ^a   Hanzawa, Ryo ^a   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Excitatory glutamate transporters (EAATs); Glutamate; Polymorphism; Schizophrenia; Solute carrier family 1, Member 2 (SLC1A2)

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 2;

ADULT; ARTICLE; BEHAVIOR GENETICS; CASE CONTROL STUDY; CATATONIC SCHIZOPHRENIA; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HEBEPHRENIA; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; JAPAN; MALE; SCHIZOPHRENIA;

EID: 68949208409     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.092     Document Type: Article

References (33)

1. Arinami T., Ohtsuki T., Ishiguro H., Ujike H., Tanaka Y., Morita Y., Mineta M., Takeichi M., Yamada S., Imamura A., Ohara K., Shibuya H., Suzuki Y., Muratake T., Kaneko N., Someya T., Inada T., Yoshikawa T., Toyota T., Yamada K., Kojima T., Takahashi S., Osamu O., Shinkai T., Nakamura M., Fukuzako H., Hashiguchi T., Niwa S.I., Ueno T., Tachikawa H., Hori T., Asada T., Nanko S., Kunugi H., Hashimoto R., Ozaki N., Iwata N., Harano M., Arai H., Ohnuma T., Kusumi I., Koyama T., Yoneda H., Fukumaki Y., Shibata H., Kaneko S., Higuchi H., Yasui-Furukori N., Numachi Y., Itokawa M., and Okazaki Y. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am. J. Hum. Genet. 77 (2005) 937-944
2. Bar-Peled O., Ben-Hur H., Biegon A., Groner Y., Dewhurst S., Furuta A., and Rothstein J.D. Distribution of glutamate transporter subtypes during human brain development. J. Neurochem. 69 (1997) 2571-2580
3. Begni S., Moraschi S., Bignotti S., Fumagalli F., Rillosi L., Perez J., and Gennarelli M. Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biol. Psychiatry 53 (2003) 617-619
4. Begni S., Popoli M., Moraschi S., Bignotti S., Tura G.B., and Gennarelli M. Association between the ionotropic glutamate receptor kainate 3 (GRIK3) ser310ala polymorphism and schizophrenia. Mol. Psychiatry 7 (2002) 416-418
5. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.P., Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.M., Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.J., Bouillot M., Sambucy J.L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M., Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D., Gimalac A., Van Duijn C., Gauvreau D., Ouellette G., Fortier I., Raelson J., Sherbatich T., Riazanskaia N., Rogaev E., Raeymaekers P., Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E., Weinberger D.R., Cohen N., and Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13675-13680
6. Corvin A., Donohoe G., McGhee K., Murphy K., Kenny N., Schwaiger S., Nangle J.M., Morris D., and Gill M. d-Amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia. Neurosci. Lett. 426 (2007) 97-100
7. Corvin A., McGhee K.A., Murphy K., Donohoe G., Nangle J.M., Schwaiger S., Kenny N., Clarke S., Meagher D., Quinn J., Scully P., Baldwin P., Browne D., Walsh C., Waddington J.L., Morris D.W., and Gill M. Evidence for association and epistasis at the DAOA/G30 and d-amino acid oxidase loci in an Irish schizophrenia sample. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 144 (2007) 949-953
8. Deng X., Shibata H., Ninomiya H., Tashiro N., Iwata N., Ozaki N., and Fukumaki Y. Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia. BMC Psychiatry 4 (2004) 21
9. Fujii Y., Shibata H., Kikuta R., Makino C., Tani A., Hirata N., Shibata A., Ninomiya H., Tashiro N., and Fukumaki Y. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr. Genet. 13 (2003) 71-76
10. Halberstadt A.L. The phencyclidine-glutamate model of schizophrenia. Clin. Neuropharmacol. 18 (1995) 237-249
11. Li D., Collier D.A., and He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum. Mol. Genet. 15 (2006) 1995-2002
12. Li X., and Francke U. Assignment of the gene SLC1A2 coding for the human glutamate transporter EAAT2 to human chromosome 11 bands p13-p12. Cytogenet. Cell Genet. 71 (1995) 212-213
13. Liu X., He G., Wang X., Chen Q., Qian X., Lin W., Li D., Gu N., Feng G., and He L. Association of DAAO with schizophrenia in the Chinese population. Neurosci. Lett. 369 (2004) 228-233
14. Liu Y.L., Fann C.S., Liu C.M., Chang C.C., Wu J.Y., Hung S.I., Liu S.K., Hsieh M.H., Hwang T.J., Chan H.Y., Chen J.J., Faraone S.V., Tsuang M.T., Chen W.J., and Hwu H.G. No association of G72 and d-amino acid oxidase genes with schizophrenia. Schizophr. Res. 87 (2006) 15-20
15. Makino C., Fujii Y., Kikuta R., Hirata N., Tani A., Shibata A., Ninomiya H., Tashiro N., Shibata H., and Fukumaki Y. Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 116B (2003) 17-22
16. Maragakis N.J., Dietrich J., Wong V., Xue H., Mayer-Proschel M., Rao M.S., and Rothstein J.D. Glutamate transporter expression and function in human glial progenitors. Glia 45 (2004) 133-143
17. McCullumsmith R.E., and Meador-Woodruff J.H. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 26 (2002) 368-375
18. Ohi K., Hashimoto R., Yasuda Y., Yoshida T., Takahashi H., Iike N., Fukumoto M., Takamura H., Iwase M., Kamino K., Ishii R., Kazui H., Sekiyama R., Kitamura Y., Azechi M., Ikezawa K., Kurimoto R., Kamagata E., Tanimukai H., Tagami S., Morihara T., Ogasawara M., Okochi M., Tokunaga H., Numata S., Ikeda M., Ohnuma T., Ueno S.I., Fukunaga T., Tanaka T., Kudo T., Arai H., Ohmori T., Iwata N., Ozaki N., and Takeda M. Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study. Schizophr. Res. 109 (2009) 80-85
19. Ohnuma T., Augood S.J., Arai H., McKenna P.J., and Emson P.C. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res. Mol. Brain Res. 56 (1998) 207-217
20. Ohnuma T., Shibata N., Maeshima H., Baba H., Hatano T., Hanzawa R., and Arai H. Association analysis of glycine- and serine-related genes in a Japanese population of patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009) 511-518
21. Ohnuma T., Suzuki T., and Arai H. Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 889-894
22. Ohnuma T., Tessler S., Arai H., Faull R.L., McKenna P.J., and Emson P.C. Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. Brain Res. Mol. Brain Res. 85 (2000) 24-31
23. Petryshen T.L., Middleton F.A., Kirby A., Aldinger K.A., Purcell S., Tahl A.R., Morley C.P., McGann L., Gentile K.L., Rockwell G.N., Medeiros H.M., Carvalho C., Macedo A., Dourado A., Valente J., Ferreira C.P., Patterson N.J., Azevedo M.H., Daly M.J., Pato C.N., Pato M.T., and Sklar P. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol. Psychiatry 10 (2005) 366-374
24. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 73-84
25. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C., Tullius M., Kovalenko S., Bogaert A.V., Maier W., Rietschel M., Propping P., Nothen M.M., and Cichon S. Examination of G72 and d-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol. Psychiatry 9 (2004) 203-207
26. Shao L., and Vawter M.P. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol. Psychiatry 64 (2008) 89-97
27. Shinkai T., De Luca V., Hwang R., Muller D.J., Lanktree M., Zai G., Shaikh S., Wong G., Sicard T., Potapova N., Trakalo J., King N., Matsumoto C., Hori H., Wong A.H., Ohmori O., Macciardi F., Nakamura J., and Kennedy J.L. Association analyses of the DAOA/G30 and d-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia. Neuromolecular Med. 9 (2007) 169-177
28. Skol A.D., Scott L.J., Abecasis G.R., and Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38 (2006) 209-213
29. Smith R.E., Haroutunian V., Davis K.L., and Meador-Woodruff J.H. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am. J. Psychiatry 158 (2001) 1393-1399
30. Takaki H., Kikuta R., Shibata H., Ninomiya H., Tashiro N., and Fukumaki Y. Positive associations of polymorphisms in the metabotropic glutamate receptor type 8 gene (GRM8) with schizophrenia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 128B (2004) 6-14
31. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., and Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276 (1997) 1699-1702
32. Wood L.S., Pickering E.H., and Dechairo B.M. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol. Psychiatry 61 (2007) 1195-1199
33. Yamada K., Ohnishi T., Hashimoto K., Ohba H., Iwayama-Shigeno Y., Toyoshima M., Okuno A., Takao H., Toyota T., Minabe Y., Nakamura K., Shimizu E., Itokawa M., Mori N., Iyo M., and Yoshikawa T. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biol. Psychiatry 57 (2005) 1493-1503